Relentlessly Pursuing the Best Possible Outcome
We've Recovered Hundreds of Millions for Our Clients
-
$30m Product Liability Verdict -
$24m Wrongful Death Settlement -
$14m Medical Device Settlement -
$13.5m Personal Injury -
$12m Child Wrongful Death
-
$11m Personal Injury
Heart Problems
Xeljanz has been found to increase the risk of a serious cardiovascular event, such as:
- Cardiac arrest
- Congestive heart failure
- Coronary revascularization
- Cardiovascular death
- Myocardial infarction
A Heightened Risk of Cancer
Xeljanz has been linked to a wide variety of cancers, such as:
- Lung cancer
- Breast cancer
- Colon cancer
- Prostate cancer
- Non-Hodgkin’s lymphoma
This is not an exhaustive list by any means. If you have developed any type of cancer after taking Xeljanz, we encourage you to consult a Xeljanz injury attorney to determine whether there may be a link.
Pfizer Should Have Warned of Xeljanz’s Health Risks
There is evidence that Pfizer knew of Xeljanz’s health risks and concealed them from the FDA: Back in 2013, it had trouble getting Xeljanz approved for use in the European Union. The Committee for Medicinal Products for Human Use, the body in charge of authorizing medicines in the EU, refused to approve Xeljanz at the proposed 10 mg dose.
During its clinical trials across the pond, Xeljanz showed a heightened risk for:
- Blood clots
- Cancer
- Liver damage
- Renal impairment
- Gastrointestinal perforations
In the last 14 years, Shoop & team's impressive track record includes hundreds of Product Liability cases resulting in verdicts or settlements exceeding $1 million. For a Product Liability team with an exemplary track record, clients choose Shoop.
Xeljanz Linked to Serious Health Conditions
Xeljaz first came under scrutiny after it was found to increase the risk of blood clots for patients with arthritis and ulcerative colitis. In particular, the FDA found that Xeljanz could increase a patient’s risk of developing blood clots in the legs, thighs, pelvis, or lungs. These findings compelled the FDA to issue a safety alert and black box warning for the drug in 2019.
Unfortunately, more health risks have come to light since then: The FDA has received reports of patients suffering not only blood clots, but also heart problems, various types of cancer, and even death. Still, both Xeljanz and Xeljanz XR remain on the market.
Blood Clots, Pulmonary Embolism, and Deep-Vein Thrombosis
The FDA received a high number of reports of pulmonary embolism (blood clots in the lungs) and deep-vein thrombosis (a type of blood clot in the legs) relating to Xeljanz use by patients with arthritis and ulcerative colitis.
Both pulmonary embolisms, or PE, and deep-vein thrombosis, or DVT, can be life-threatening. In fact, from 2013 to 2018, the FDA received reports of 15 patient deaths from PEs and DVTs relating to Xeljanz.
-lg.2309181221228.png "Top 100 Trial Lawyers")
.1).2309181221550.png "Super Lawyers")
Book a Free Consultation with a Xeljanz Injury Lawyer
If your Xeljanz lawsuit is successful, Pfizer may be held liable for damages directly resulting from the drug, such as the cost of the medication itself, the other medical expenses it caused, pain and suffering, lost wages, and more. For cases involving wrongful death due to Xeljanz, plaintiffs may be qualified to recover damages incurred due to their bereavement, like funeral expenses and the loss of comfort, companionship, society, love, moral support, etc.
At Shoop | A Professional Law Corporation, we know how to take on large corporations and win. In the past 35 years, our lawyers have recovered more than $550 million in client recoveries through our tailored, tenacious representation. Now, we are prepared to take on Pfizer on your behalf—we will fight to maximize your compensation.
Contact a Los Angeles trial lawyer online today to find out if you qualify for a Xeljanz lawsuit. Your consultation will be provided at no cost to you!